Misoprostol Could Help Save Women's Lives, Opinion Piece Says
Main Category: Women's Health / GynecologyAlso Included In: Pregnancy / Obstetrics
Article Date: 13 May 2009 - 5:00 PDT
| Patient / Public: | ![]() |
4.67 (3 votes) |
| Healthcare Prof: | ![]() |
5 (1 votes) |
"Every minute, a woman somewhere in the world dies in childbirth or from complications of pregnancy," Amy Grossman, communications manager for Venture Strategies for Health and Development, writes in a New York Times opinion piece, adding that misoprostol is "an inexpensive medicine that could save a great many of these women's lives." She adds that the generic drug -- "originally developed to treat ulcers but ... predominately used off-label for obstetrics" -- can "effectively stop" postpartum hemorrhaging if taken immediately after delivery. According to Grossman, postpartum hemorrhage, or excessive bleeding, is the "leading cause of maternal death in most developing countries." She continues, "What's more, it's an easy-to-take tablet with a long shelf-life," it "can be manufactured for as little as four cents a tablet, and in developing countries, a three-tablet dose goes for about a dollar."
However, she writes, "Because of its use in abortion, the drug's availability is limited." The "abortion debate should not obscure the benefits of its use in safe childbirth," Grossman adds. According to Grossman, "the United Nations has called for a drastic reduction in maternal mortality by 2015," and to "this end, my organization has had success working with agencies and governments to increase access to misoprostol to prevent unnecessary maternal deaths from postpartum hemorrhage, but there's more work ahead." She concludes that no woman should have to fear "dying in childbirth" (Grossman, New York Times, 5/10).
Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.
© 2009 The Advisory Board Company. All rights reserved.
Visit our women's health / gynecology section for the latest news on this subject.
MLA
11 Feb. 2012. <http://www.medicalnewstoday.com/releases/149831.php>
APA
http://www.medicalnewstoday.com/releases/149831.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



